[13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum

C52H39N5OPt — CID 171724276

IUPAC[13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
SMILESCc1cc(-n2c3ccc(-c4ccccc4)cc3c3ccc(Oc4cccc(-n5cc6c7cnc(n6c5=[Pt])CCc5ccc(cc5)CC7)c4)cc32)ncc1-c1ccccc1
InChIInChI=1S/C52H39N5O.Pt/c1-35-27-52(54-32-47(35)39-11-6-3-7-12-39)57-48-25-22-40(38-9-4-2-5-10-38)28-46(48)45-24-23-44(30-49(45)57)58-43-14-8-13-42(29-43)55-33-50-41-21-19-36-15-17-37(18-16-36)20-26-51(53-31-41)56(50)34-55;/h2-18,22-25,27-33H,19-21,26H2,1H3;
InChIKeyURBQDTXWEKWPFU-UHFFFAOYSA-N
MW945.00 g/mol
LogP12.01
Rot. Bonds6

About [13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum

[13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum (PubChem CID 171724276) has the molecular formula C52H39N5OPt and a molecular weight of 945.00 g/mol. Its IUPAC name is [13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum.

Molecular Properties

Compound Name[13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
PubChem CID171724276
Molecular FormulaC52H39N5OPt
Molecular Weight945.00 g/mol
Exact Mass944.28
IUPAC Name[13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
SMILESCc1cc(-n2c3ccc(-c4ccccc4)cc3c3ccc(Oc4cccc(-n5cc6c7cnc(n6c5=[Pt])CCc5ccc(cc5)CC7)c4)cc32)ncc1-c1ccccc1
InChIInChI=1S/C52H39N5O.Pt/c1-35-27-52(54-32-47(35)39-11-6-3-7-12-39)57-48-25-22-40(38-9-4-2-5-10-38)28-46(48)45-24-23-44(30-49(45)57)58-43-14-8-13-42(29-43)55-33-50-41-21-19-36-15-17-37(18-16-36)20-26-51(53-31-41)56(50)34-55;/h2-18,22-25,27-33H,19-21,26H2,1H3;
InChIKeyURBQDTXWEKWPFU-UHFFFAOYSA-N
XLogP12.01
TPSA49.28 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500945.00
LogP ≤ 512.01
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze [13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The IUPAC name of [13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum (CID 171724276) is [13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum.
What is the SMILES notation for [13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The canonical SMILES for [13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum is Cc1cc(-n2c3ccc(-c4ccccc4)cc3c3ccc(Oc4cccc(-n5cc6c7cnc(n6c5=[Pt])CCc5ccc(cc5)CC7)c4)cc32)ncc1-c1ccccc1.
What is the InChIKey of [13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The InChIKey is URBQDTXWEKWPFU-UHFFFAOYSA-N. The full InChI is InChI=1S/C52H39N5O.Pt/c1-35-27-52(54-32-47(35)39-11-6-3-7-12-39)57-48-25-22-40(38-9-4-2-5-10-38)28-46(48)45-24-23-44(30-49(45)57)58-43-14-8-13-42(29-43)55-33-50-41-21-19-36-15-17-37(18-16-36)20-26-51(53-31-41)56(50)34-55;/h2-18,22-25,27-33H,19-21,26H2,1H3;.
What are the key properties of [13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
[13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum has a molecular weight of 945.00 g/mol, XLogP of 12.01, 6 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [13-[3-[9-(4-methyl-5-phenyl-2-pyridinyl)-6-phenylcarbazol-2-yl]oxyphenyl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum is sourced from PubChem (CID 171724276), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).